A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.

Hanxi Zhao; Wanqi Zhu; Peng Xie; Huiqin Li; Xiqin Zhang; Xiaorong Sun; Jinming Yu; Ligang Xing

首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.

【24h】

A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.

机译：一项针对局部晚期III期非小细胞肺癌患者同时进行化学疗法和胸腔放疗并联合口服表没食子儿茶素-3-没食子酸酯的研究。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

We conclude that the oral administration of EGCG is feasible, safe and effective. The phase II recommended concentration is 440 μmol/L.

机译：我们认为口服EGCG是可行，安全和有效的。 II期推荐浓度为440μmol/ L。

著录项

来源
《Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology》 |2014年第1期|共5页
作者
Hanxi Zhao; Wanqi Zhu; Peng Xie; Huiqin Li; Xiqin Zhang; Xiaorong Sun; Jinming Yu; Ligang Xing;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer. [J] . Hanxi Zhao, Wanqi Zhu, Peng Xie, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2014,第1期

机译：一项针对局部晚期III期非小细胞肺癌患者同时进行化学疗法和胸腔放疗并联合口服表没食子儿茶素-3-没食子酸酯的研究。
2. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer. [J] . Lee S, Choi EK, Lee JS, International Journal of Radiation Oncology, Biology, Physics . 2003,第4期

机译：三维共形放疗和同时进行的丝裂霉素-C，长春碱和顺铂化疗的II期研究，用于III期局部晚期，不可切除的非小细胞肺癌。
3. Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non-Small-Cell Lung Cancer. [J] . Choy H, Nabid A, Stea B, Journal of Clinical Oncology . 2005,第25期

机译：局部晚期非小细胞肺癌患者诱导化疗联合并用依法洛昔洛韦（RSR13）和胸腔放疗的II期多中心研究。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer [O] . Ahmad A. Tarhini, Chandra P. Belani, James D. Luketich, -1

机译：局部晚期III期非小细胞肺癌患者吞咽化学疗法（紫杉醇和卡铂）和胸腔放疗联合吞咽锰超氧化物歧化酶质粒脂质体保护的I期研究
7. A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer [O] . Tarhini, Ahmad A., Belani, Chandra P., Luketich, James D., 2011

机译：局部晚期III期非小细胞肺癌患者吞咽化学疗法（紫杉醇和卡铂）和胸腔放疗联合吞咽锰超氧化物歧化酶质粒脂质体保护的I期研究

A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.

摘要

著录项

相似文献

相关主题

期刊订阅